GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (STU:R5XA) » Definitions » Cyclically Adjusted PB Ratio

Talphera (STU:R5XA) Cyclically Adjusted PB Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Talphera Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Talphera Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Talphera's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Cyclically Adjusted PB Ratio Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.70 3.70 3.34 0.89 2.32

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.51 0.41 2.32 -

Competitive Comparison of Talphera's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talphera's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Talphera's Cyclically Adjusted PB Ratio falls into.



Talphera Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Talphera's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Talphera's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.884/131.7762*131.7762
=0.884

Current CPI (Mar. 2024) = 131.7762.

Talphera Quarterly Data

Book Value per Share CPI Adj_Book
201406 18.852 100.560 24.704
201409 20.980 100.428 27.529
201412 17.312 99.070 23.027
201503 17.126 99.621 22.654
201506 13.409 100.684 17.550
201509 16.024 100.392 21.033
201512 13.429 99.792 17.733
201603 9.292 100.470 12.187
201606 5.302 101.688 6.871
201609 1.286 101.861 1.664
201612 -2.232 101.863 -2.887
201703 -8.101 102.862 -10.378
201706 -12.404 103.349 -15.816
201709 -10.245 104.136 -12.964
201712 -12.122 104.011 -15.358
201803 -14.912 105.290 -18.663
201806 -15.720 106.317 -19.484
201809 -10.482 106.507 -12.969
201812 0.949 105.998 1.180
201903 -1.771 107.251 -2.176
201906 -4.131 108.070 -5.037
201909 -6.453 108.329 -7.850
201912 -9.369 108.420 -11.387
202003 -12.443 108.902 -15.057
202006 -13.202 108.767 -15.995
202009 -10.857 109.815 -13.028
202012 -9.275 109.897 -11.122
202103 -3.852 111.754 -4.542
202106 -5.013 114.631 -5.763
202109 -6.130 115.734 -6.980
202112 -4.643 117.630 -5.201
202203 -4.725 121.301 -5.133
202206 4.256 125.017 4.486
202209 3.713 125.227 3.907
202212 2.498 125.222 2.629
202303 1.218 127.348 1.260
202306 0.875 128.729 0.896
202309 1.012 129.860 1.027
202312 0.763 129.419 0.777
202403 0.884 131.776 0.884

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Talphera  (STU:R5XA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Talphera Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Talphera's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Talphera (STU:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (STU:R5XA) Headlines

No Headlines